Drausin Wulsin

Join Drausin Wulsin, Director of ML at Immunai, as he explores the groundbreaking intersection of AI and immunotherapy. He discusses how AI is revolutionizing treatments for cancer and autoimmune diseases by analyzing vast biological data. Wulsin highlights the innovative immune database AMICA, which leverages advanced machine learning techniques. The conversation also touches on the significance of transfer learning and the collaborative future of AI in drug discovery, promising exciting advancements in therapeutic development.

Drausin Wulsin, Director of Machine Learning at Immunai, shares his expertise in using AI for immunotherapy and genomics. He discusses how AI transforms the treatment landscape for cancer and autoimmune diseases. The conversation dives into the creation of the AMICA database, which holds tens of millions of immune cells, and the innovative use of transfer learning to enhance biological research. The challenges of integrating AI into immunology and the future potential of AI in biotechnology highlight a fascinating intersection of technology and health.